term peptide FAQ

If the peptides remained frozen (ice still present in the freezer) and power was restored within 12 hours, they're likely fine. Lyophilised peptides tolerate brief temperature increases better than reconstituted ones. If the freezer fully thawed (no ice, interior temperature above 10°C for multiple hours), assess on a peptide-by-peptide basis. Copper peptides (GHK-Cu) and BPC-157 are relatively stable and may retain 80–90% potency; shorter-chain peptides like Epithalon or Thymosin Beta-4 fragments degrade faster. When in doubt, contact the supplier. Some companies offer discounted replacements for documented storage failures.

Discard it. A reconstituted peptide solution left at room temperature (20–25°C) for 8+ hours has undergone significant degradation. The peptide backbone begins cleaving within 4–6 hours at ambient temperature, and bacterial contamination risk compounds every hour beyond that. Bacteriostatic water delays microbial growth but does not stop it; by morning, the solution is chemically compromised and potentially unsafe. The financial loss of one vial is negligible compared to the risk of injecting a degraded or contaminated solution.

You'll hit the 28-day stability ceiling before finishing the vial. The options are: (1) discard the remaining solution after 28 days and accept the waste, (2) adjust your protocol to use the peptide more frequently and finish it within the window, or (3) split the lyophilised powder into smaller vials before reconstitution using aseptic technique in a sterile environment. The third option requires advanced lab skills and increases contamination risk, so most researchers default to option (1) and reconstitute smaller vials more frequently. Our team's consistent recommendation is to order smaller vial sizes matched to your actual usage timeline rather than attempting to extend the post-reconstitution window.

This is suboptimal but manageable if fluctuations are brief. Prolonged exposure above 8°C accelerates degradation, but short spikes during door openings or defrost cycles are unlikely to destroy potency within the 28-day window. To minimize risk, store the vial on a middle shelf away from the door, where temperature is most stable. If your refrigerator consistently exceeds 8°C, consider using a dedicated laboratory refrigerator or a portable medication cooler.

If the lyophilized powder remained frozen (ice crystals still present when you check it), it's likely still viable. But stability is compromised. Use it within 6 months rather than the standard 12–24-month window. If the vial thawed completely, condensation inside the container has already begun hydrolysis. Reconstitute and use it immediately rather than refreezing.

Check the duration and whether the vials thawed. Lyophilised peptides tolerate brief temperature increases better than reconstituted solutions. If the power outage lasted under 12 hours and the freezer remained closed, the internal temperature likely stayed below 0°C and the peptides are salvageable. If the outage exceeded 24 hours or the vials reached room temperature, potency degrades but doesn't immediately vanish. Peptides that underwent one freeze-thaw cycle in lyophilised form retain approximately 85–90% of original activity if refrozen promptly. Multiple cycles compound the loss. Three cycles typically reduce potency by 30–40%. If you're uncertain about temperature history, reconstitute a small test vial and observe for cloudiness or precipitation, which signals aggregation. For critical research applications, discard and reorder rather than risk inconsistent results from thermally stressed material.

Check the vial temperature when power is restored. If the lyophilised peptide remained below 0°C (still frozen solid), it's likely stable. Peptide degradation below freezing is negligible over short timelines. If the vial thawed completely (reached 10–15°C), treat it as compromised. A single thaw event doesn't destroy the peptide, but you've used one of your maximum three freeze-thaw cycles. Mark the vial and prioritise it for near-term reconstitution rather than extended storage.

Discard the vial. A reconstituted peptide exposed to room temperature (20–25°C) for 8+ hours has undergone significant hydrolytic degradation. Likely 30–50% potency loss depending on the specific peptide sequence. Shorter peptides (under 10 amino acids) degrade faster than longer ones. There's no reliable home test to assess remaining potency, and using a degraded peptide introduces uncontrolled variables into research protocols. The cost of replacing the vial is lower than the cost of unreliable data.

Use it. Reconstituted P21 in bacteriostatic water maintains 90–92% potency at three weeks when refrigerated continuously at 2–8°C. The 28-day window is the outer stability limit. Not a cliff where peptide suddenly becomes unusable. Beyond 28 days, hydrolysis accelerates and purity drops below research-grade thresholds, but at three weeks you're within the validated stability range.

Move the vial back to −20°C immediately and assess duration and ambient temperature. If exposure was under 12 hours at 20–25°C, potency loss is likely 5–10%. Still usable for most research protocols but not ideal. Above 12 hours or at temperatures exceeding 30°C, expect 20–30% degradation. Peptides don't 'go bad' suddenly. Degradation is cumulative. You can proceed with the protocol but should increase dose proportionally or note potential reduced efficacy in documentation. Visual inspection is meaningless. Degraded SS-31 looks identical to intact peptide.

Discard the vial. Reconstituted peptides left at room temperature for 8+ hours show structural changes detectable by mass spectrometry, and there's no reliable way to verify potency without laboratory equipment. The cost of replacing the vial is lower than the risk of injecting degraded peptide with unknown efficacy.

Ship lyophilized P21 on dry ice (−78°C) in an insulated container rated for 24–48 hour transit. Include a temperature logger if possible. You want documentation that the peptide never rose above −20°C during shipping. Never ship reconstituted peptide. The risk of temperature excursion during transit is too high. If the collaborator needs ready-to-use peptide, reconstitute it at their facility upon arrival.

Discard it. Eight hours at room temperature (22–25°C) causes 30–50% peptide degradation depending on initial concentration and solution pH. The tripeptide structure is particularly vulnerable to oxidative breakdown in aqueous solution at ambient temperature. You cannot visually assess potency loss, and using a degraded peptide introduces uncontrolled variables into your research protocol that negate any data you collect.

Discard the vial if it reached room temperature for more than four hours. Lyophilised peptides that fully thaw undergo moisture absorption from ambient air, which triggers hydrolysis even if the powder appears dry. If your freezer remained below 0°C (partial thaw), the peptide likely retained 70–80% stability. You can continue using it but should reduce the expected shelf life from 24 months to 6–9 months and increase experimental concentrations by 20% to compensate for presumed potency loss. There's no visual indicator of peptide degradation in lyophilised form. Temperature logging is your only reliable evidence.

If the outage lasted fewer than 4 hours and the vial remained sealed, the peptide is likely intact. Lyophilized Semax tolerates brief temperature increases to 10–15°C without immediate degradation because the absence of water prevents hydrolysis. If the outage exceeded 4 hours or the vial warmed to room temperature, potency loss is possible but not guaranteed. The peptide may retain 80–90% activity. Reconstitute and use it for less critical applications, or order a replacement vial if full potency is required.

Use a validated peptide cooler that maintains 2–8°C for the full transport duration. Standard insulin coolers work for trips up to 36 hours; longer transport requires dry ice (for lyophilised peptides) or a laboratory cold chain shipper with temperature logging. Never transport reconstituted peptides without cold chain verification. A 4-hour excursion to 15–20°C during ground shipping can reduce potency by 8–12%, and you'll have no way to detect it until inconsistent results appear weeks later in your protocol.

Place lyophilized vials inside a small insulated container (styrofoam box or thick-walled plastic) within the freezer. This buffers the temperature swings during defrost cycles, which can reach −10°C to −5°C repeatedly. Each cycle introduces condensation risk inside the vial, and water is the catalyst for peptide bond hydrolysis even in lyophilized form. Insulation extends stable storage from months to the full manufacturer-specified shelf life.

A single overnight temperature excursion to 15°C causes approximately 10–15% potency loss in reconstituted IGF-1 LR3. The peptide is still usable but no longer at full strength. If you're running a dose-dependent research protocol where precision matters, consider the vial compromised and start a fresh one. If the application tolerates some variance, continue using it but make a note of the temperature failure in your protocol records. Do not attempt to 'compensate' by increasing dose. That introduces uncontrolled variables. The peptide doesn't become unsafe; it simply becomes less effective.

This is borderline acceptable but suboptimal. The 2–8°C range exists as a safety margin. 6–8°C is fine, but 10°C accelerates hydrolysis measurably. If your refrigerator regularly exceeds 8°C, either recalibrate the thermostat or use a dedicated laboratory refrigerator with tighter temperature control. You can extend stability slightly by placing the SS-31 vial toward the back of the refrigerator where temperature is most stable, away from the door. Use the reconstituted solution within 21 days instead of the full 28-day window if fluctuations are frequent.

Assume 15–25% potency loss and adjust your experimental dosing accordingly. Reconstituted peptide left at 15–20°C undergoes accelerated aggregation and partial denaturation. The solution may still appear clear because microaggregates remain suspended, but binding affinity to amylin receptors has decreased. Do not return the vial to the refrigerator and assume it's fine. Either increase your working concentration by 20–30% to account for reduced potency, or discard the solution and reconstitute a fresh aliquot. For critical assays where precise dosing matters, always discard after thermal excursions. The cost of repeating an experiment due to inconsistent peptide activity exceeds the cost of a new vial.